W. Timmermann et al., Videomicroscopic imaging of graft mucosa for monitoring immunosuppressive therapy after small intestinal transplantation in rats, TRANSPLANT, 67(12), 1999, pp. 1555-1561
Background. Early diagnosis of rejection and effective immunosuppressive tr
eatment are essential after small intestinal transplantation. To date littl
e is known about microscopic alterations of the intestinal mucosa of the gr
aft during rejection. We attempted to determine whether videomicroscopic im
aging of the graft mucosa is a suitable method for monitoring immunosuppres
sive therapy.
Methods. Real-time videomicroscopic imaging of an ileostoma was performed d
aily after allogeneic heterotopic small bowel transplantation in the rat (B
N to LEW) with and without FK506 immunosuppression. Subsequently, the video
microscopic findings were compared with the histologically determined grade
of rejection.
Results. A semiquantitative staging system was established for the intravit
al mucosal changes during graft rejection. The earliest changes related to
rejection appeared on POD 6 in the untreated allogeneic group. The mucosa d
eveloped patchy paleness and the mucosal architecture was interrupted in pl
aces. The crypts were slightly widened and their color turned dark red (sta
ge I). These alterations spread progressively over the mucosa on POD 7 (sta
ge II). On POD 9 the mucosa appeared pale, the villi were shortened, and th
e crypts appeared wide and rounded (stage III). In the animals treated with
FK506 similar changes were observed, but with a delayed onset. When FK506
was administered as antirejection therapy at the onset of rejection, a temp
orary improvement of mucosal alterations was observed (stage II --> stage I
). The videomicroscopic stages correlated with the histological grade of re
jection.
Conclusions. The introduction of videomicroscopy has made computer-based hi
gh resolution imaging of mucosal microarchitecture possible. With videomicr
oscopy beginning rejection can be detected, although it can still be revers
ed with antirejection therapy. This is a new noninvasive technique that mig
ht be of high clinical relevance.